-
Published 4/1/2025
Bovell-Ammon BJ, Evans L, Geissler KH. Individual- vs Neighborhood-Level Measures of Social Risk. JAMA Netw Open. 2025 Apr 01; 8(4):e255054. PMID: 40232725.
-
Published 3/19/2025
Lodi S, Yan S, Bovell-Ammon B, Christine PJ, Hsu HE, Bernson D, Novo P, Lee JD, Rotrosen J, Liebschutz JM, Walley AY, Larochelle MR. Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone on treatment interruption: Comparing findings from a reanalysis of the X:BOT RCT and harmonized target trial emulation using population-based observational data. Addiction. 2025 Mar 19. PMID: 40104887.
-
Published 12/17/2024
Bovell-Ammon BJ, Onofrey S, Kimmel SD, Wurcel AG, Klevens M. Incarceration history and HIV testing among people who inject drugs in the Boston metro area: a pooled cross-sectional study. Res Sq. 2024 Dec 17. PMID: 39764124.
-
Published 7/16/2024
Bovell-Ammon BJ, Yan S, Dunn D, Evans EA, Friedmann PD, Walley AY, LaRochelle MR. Receipt of medications for opioid use disorder before and after incarceration in Massachusetts State prisons, 2014-2019. Drug Alcohol Depend. 2024 Sep 01; 262:111392. PMID: 39029371.
-
Published 3/22/2024
Christine PJ, Lodi S, Hsu HE, Bovell-Ammon B, Yan S, Bernson D, Novo P, Lee JD, Rotrosen J, Liebschutz J, Walley AY, Larochelle MR. Target trial emulation for comparative effectiveness research with observational data: Promise and challenges for studying medications for opioid use disorder. Addiction. 2024 Jul; 119(7):1313-1321. PMID: 38519819.